SPXV:ARCA-ProShares S&P 500 Ex-Health Care (USD)

ETF | Large Blend | NYSE Arca

Last Closing

USD 65.999

Change

0.00 (0.00)%

Market Cap

USD 1.15M

Volume

1.20K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks investment results, before fees and expenses that track the performance of the S&P 500? Ex-Health Care Index (the "index"). Under normal circumstances, the fund will invest at least 80% of its total assets in component securities. The index seeks to provide exposure to the companies of the S&P 500? Index (the "S&P 500?") with the exception of those companies included in the Health Care Sector.

Inception Date: 22/09/2015

Primary Benchmark: S&P 500 Ex-Health Care USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.27%

Management Expense Ratio: 0.27 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-25 )

Largest Industry Peers for Large Blend

Symbol Name Mer Price(Change) Market Cap
VTI Vanguard Total Stock Market In.. 0.03 %

N/A

USD 454.13B
SPLG SPDR® Portfolio S&P 500 ETF 0.04 %

N/A

USD 53.49B
SCHX Schwab U.S. Large-Cap ETF 0.03 %

N/A

USD 51.13B
DYNF BlackRock US Equity Factor Rot.. 0.00 %

N/A

USD 13.65B
GSLC Goldman Sachs ActiveBeta® U.S.. 0.09 %

N/A

USD 13.10B
SPTM SPDR® Portfolio S&P 1500 Comp.. 0.04 %

N/A

USD 9.65B
SPLV Invesco S&P 500® Low Volatili.. 0.25 %

N/A

USD 7.14B
JQUA JPMorgan U.S. Quality Factor E.. 0.12 %

N/A

USD 5.20B
SCHK Schwab 1000 ETF 0.05 %

N/A

USD 3.97B
DIVO Amplify CWP Enhanced Dividend .. 0.94 %

N/A

USD 3.77B

ETFs Containing SPXV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Large Blend) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.69% 36% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.69% 36% F 62% D
Trailing 12 Months  
Capital Gain 27.75% 92% A 82% B
Dividend Return 1.00% 45% F 15% F
Total Return 28.75% 92% A 82% B
Trailing 5 Years  
Capital Gain 94.89% 89% A- 85% B
Dividend Return 9.08% 56% F 27% F
Total Return 103.97% 90% A- 84% B
Average Annual (5 Year Horizon)  
Capital Gain 14.55% 65% D 74% C
Dividend Return 15.87% 69% C- 73% C
Total Return 1.32% 57% F 32% F
Risk Return Profile  
Volatility (Standard Deviation) 21.60% 29% F 51% F
Risk Adjusted Return 73.48% 46% F 83% B
Market Capitalization 1.15M 12% F 14% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.